MPM
MRNA icon

MBB Public Markets’s Moderna MRNA Stock Holding History

MBB Public Markets’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,681
Closed -$212K – 331
2025
Q2 		$212K Sell
7,681
-1,864
-20% -$49.1K 0.02% 485
2025
Q1 		$271K Buy
+9,545
New +$339K 0.03% 521
2024
Q3 		– Sell
-23,700
Closed -$2.81M – 651
2024
Q2 		$2.81M Buy
+23,700
New +$3M 0.06% 271
2022
Q1 		– Sell
-2,157
Closed -$548K – 313
2021
Q4 		$548K Buy
+2,157
New +$631K 0.01% 213

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MBB Public Markets's MRNA Position: Q3 2025 in Review

MBB Public Markets sold out of Moderna (MRNA) in Q3 2025, closing a stake of 7,681 shares — an estimated $212K sold.

MBB Public Markets first reported a position in MRNA in Q4 2021 and held it in 4 quarters. The position peaked at $2.81M in Q2 2024. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • MBB Public Markets reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • MBB Public Markets sold 7,681 Moderna shares in Q3 2025, an estimated $212K.
  • MBB Public Markets first reported a position in Moderna in Q4 2021 and held it in 4 quarters.
  • MBB Public Markets's Moderna position peaked at $2.81M in Q2 2024.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on MBB Public Markets's 13F filing for Q3 2025, filed 14 Nov 2025.